Parallel Advisors, LLC Biotechnology

Parallel Advisors, LLC

$4.31 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
VXRT Vaxart, Inc.	$50.6M	$1,000 0.0% of portfolio	3,000	Q2 2023 Reduced 2.45%
LBPS 4 D Pharma PLC	$37.2M	$0 0.0% of portfolio	5	Q1 2025 New
ETNB 89bio, Inc.	$326M	$0 0.0% of portfolio	25	Q1 2025 New
ADAP Adaptimmune Therapeutics PLC	$45.7M	$0 0.0% of portfolio	250	Q4 2024 Reduced 96.52%
ALDX Aldeyra Therapeutics, Inc.	$156M	$0 0.0% of portfolio	30	Q1 2025 New
ALLK Allakos Inc.	$28M	$0 0.0% of portfolio	770	Q2 2024 Reduced 37.35%
ALLO Allogene Therapeutics, Inc.	$223M	$0 0.0% of portfolio	114	Q1 2025 Reduced 48.42%
ALT Altimmune, Inc.	$249M	$0 0.0% of portfolio	40	Q3 2022 Reduced 90.91%
AMRN Amarin Corp Plcuk	$4.21B	$0 0.0% of portfolio	200	Q4 2022 Reduced 87.58%
ARQT Arcutis Biotherapeutics, Inc.	$879M	$0 0.0% of portfolio	14	Q1 2025 Reduced 50.0%
ARWR Arrowhead Pharmaceuticals, Inc.	$1.4B	$0 0.0% of portfolio	59	Q1 2025 Reduced 94.79%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	38	Q1 2025 Added 123.53%
AUPH Aurinia Pharmaceuticals Inc.	$1.16B	$0 0.0% of portfolio	43	Q4 2024 New
BNTX Bio N Tech Se	$24.8B	$0 0.0% of portfolio	3	Q1 2025 Reduced 98.82%
CAPR Capricor Therapeutics, Inc.	$309M	$0 0.0% of portfolio	13	Q4 2024 New
SAVA Cassava Sciences Inc	$63M	$0 0.0% of portfolio	244	Q2 2024 Reduced 3.94%
CPRX Catalyst Pharmaceuticals, Inc.	$2.41B	$0 0.0% of portfolio	27	Q4 2024 Added 107.69%
KDNY Chinook Therapeutics, Inc.	$0	$0 0.0% of portfolio	5	Q3 2023 Reduced 80.77%
CDXS Codexis, Inc.	$148M	$0 0.0% of portfolio	200	Q3 2023 Reduced 50.0%
DAWN Day One Biopharmaceuticals, Inc.	$569M	$0 0.0% of portfolio	4	Q4 2024 New
DYN Dyne Therapeutics, Inc.	$573M	$0 0.0% of portfolio	27	Q4 2024 Reduced 3.57%
EDIT Editas Medicine, Inc.	$106M	$0 0.0% of portfolio	60	Q3 2024 Reduced 74.47%
EYPT Eye Point Pharmaceuticals, Inc.	$217M	$0 0.0% of portfolio	121	Q1 2025 New
HRTX Heron Therapeutics, Inc.	$273M	$0 0.0% of portfolio	200	Q3 2023 Reduced 75.7%
IMUX Immunic, Inc.	$34.8M	$0 0.0% of portfolio	2	Q2 2019 New
IMVT Immunovant, Inc.	$3.55B	$0 0.0% of portfolio	7	Q1 2025 Reduced 81.58%
IOVA Iovance Biotherapeutics, Inc.	$554M	$0 0.0% of portfolio	86	Q1 2025 Reduced 74.48%
JANX Janux Therapeutics, Inc.	$1.29B	$0 0.0% of portfolio	7	Q1 2025 Added 250.0%
KURA Kura Oncology, Inc.	$430M	$0 0.0% of portfolio	0	Q1 2025 Sold Out
KYMR Kymera Therapeutics, Inc.	$1.82B	$0 0.0% of portfolio	28	Q1 2025 Added 115.38%
PRTA Prothena Corp Public LTD CO	$455M	$0 0.0% of portfolio	70	Q4 2024 New
CRTX Cortexyme, Inc.	$70.5M	$0 0.0% of portfolio	295	Q2 2024 Reduced 5.14%
RGNX Regenxbio Inc.	$396M	$0 0.0% of portfolio	50	Q2 2023 Reduced 7.41%
RLAY Relay Therapeutics, Inc.	$385M	$0 0.0% of portfolio	74	Q1 2025 New
SANA Sana Biotechnology, Inc.	$337M	$0 0.0% of portfolio	67	Q1 2025 Reduced 62.78%
SLDB Solid Biosciences Inc.	$25.9M	$0 0.0% of portfolio	7	Q2 2024 Added 16.67%
STOK Stoke Therapeutics, Inc.	$385M	$0 0.0% of portfolio	24	Q1 2025 New
STRO Sutro Biopharma, Inc.	$57.4M	$0 0.0% of portfolio	465	Q3 2023 Added 0.19%
TSHA Taysha Gene Therapies, Inc.	$84.6M	$0 0.0% of portfolio	280	Q2 2024 New
TPST Tempest Therapeutics, Inc.	$81.3M	$0 0.0% of portfolio	236	Q1 2025 Added 0.43%
VNDA Vanda Pharmaceuticals Inc.	$240M	$0 0.0% of portfolio	87	Q2 2023 Added 188.5%
VERV Verve Therapeutics, Inc.	$345M	$0 0.0% of portfolio	23	Q3 2024 New
VIRX Viracta Therapeutics, Inc.	$751K	$0 0.0% of portfolio	8	Q1 2021 New
WVE Wave Life Sciences Ltd.	$575M	$0 0.0% of portfolio	95	Q1 2023 New
AADI Aadi Bioscience, Inc.	$35.9M	$0 0.0% of portfolio	8	Q2 2024 Reduced 100.0%
XNCR Xencor Inc	$627M	$0 0.0% of portfolio	63	Q1 2025 Reduced 53.68%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.